WITHDRAWAL SYMPTOMS AS A PREDICTOR OF MORTALITY IN PATIENTS HIV-INFECTED THROUGH DRUG USE AND RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
Guardado en:
MICHEL, L., ET AL., WITHDRAWAL SYMPTOMS AS A PREDICTOR OF MORTALITY IN PATIENTS HIV-INFECTED THROUGH DRUG USE AND RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART). DRUG AND ALCOHOL DEPENDENCE, Vol. 99, no. 1-3 (2009), p. 96-104.
Ref.
160751
Localización:
SIIS R.854 Archivo
Palabras clave:
Desintoxicación, Drogodependencias, Factor de riesgo, Mortalidad, Sida, Síndrome de abstinencia, Tratamiento, Vía intravenosa, Francia
Desintoxicación, Drogodependencias, Factor de riesgo, Mortalidad, Sida, Síndrome de abstinencia, Tratamiento, Vía intravenosa, Francia
Ejemplares similares: WITHDRAWAL SYMPTOMS AS A PREDICTOR OF MORTALITY IN PATIENTS HIV-INFECTED THROUGH DRUG USE AND RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART)
- USE OF ANTIRETROVIRAL THERAPIES BY HIV-INFECTED PERSONS RECEIVING METHADONE MAINTENANCE
- ACCES TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) FOR INJECTING DRUG USERS IN THE WHO EUROPEAN REGION 2002-2004
- "HAART": IMPACT OF MORTALITY, MORBIDITY PATTERNS AND SERVICE REQUIREMENTS FOR PEOPLE INFECTED WITH HIV
- THE IMPACT OF METHADONE OR BUPRENORPHINE TREATMENT AND ONGOING INJECTION ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) ADHERENCE: EVIDENCE FROM THE MANIF2000 COHORT STUDY
- Ongoing impact of HIV infection on mortality among people who inject drugs despite free antiretroviral therapy
- A frailty related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV infected men